Literature DB >> 11782959

Osteopontin: a novel axon-regulated Schwann cell gene.

Sebastian Jander1, Simona Bussini, Eva Neuen-Jacob, Frank Bosse, Til Menge, Hans-Werner Müller, Guido Stoll.   

Abstract

Osteopontin (OPN) is a RGD-containing glycoprotein with cytokine-like, chemotactic, and pro-adhesive properties. During wound healing, OPN is abundantly expressed by infiltrating macrophages and has been implicated in posttraumatic tissue repair. To delineate a role in the regenerative response to axotomy we examined the expression of OPN in Wallerian degeneration of the sciatic nerve in rats. Unexpectedly, we found high constitutive expression of OPN by myelinating Schwann cells (SCs) in uninjured control nerves. OPN mRNA expression was confirmed in primary cultures of rat SCs. Upon axotomy, SC-expressed OPN in the degenerating distal nerve stump transiently increased during the first days after injury, but was continuously downregulated thereafter, reaching its minimum at Day 14. Macrophages invading axotomized nerves were OPN-negative. During late stages after axotomy, SC-OPN was reexpressed in regenerating but not permanently transected nerves. We also found OPN expression by myelinating SCs in human sural nerves with a dramatic reduction in severe axonal polyneuropathies. Taken together, our study identifies OPN as a novel Schwann cell gene regulated by axon-derived signals. The lack of OPN induction in infiltrating macrophages indicates fundamental differences in tissue repair between axonal injury in the peripheral nervous system and structural lesions in other organ systems. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782959     DOI: 10.1002/jnr.10099

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Osteopontin and clusterin levels in type 2 diabetes mellitus: differential association with peripheral autonomic nerve function.

Authors:  Raelene E Maser; M James Lenhard; Ryan T Pohlig; P Babu Balagopal
Journal:  Neurol Sci       Date:  2017-06-21       Impact factor: 3.307

2.  SPP1 promotes Schwann cell proliferation and survival through PKCα by binding with CD44 and αvβ3 after peripheral nerve injury.

Authors:  Jiang-Bo Wang; Zhan Zhang; Jian-Nan Li; Tuo Yang; Shuang Du; Rang-Juan Cao; Shu-Sen Cui
Journal:  Cell Biosci       Date:  2020-08-20       Impact factor: 7.133

3.  A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approach.

Authors:  Albert Ries; Jeffrey L Goldberg; Barbara Grimpe
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

4.  The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems.

Authors:  Yasuto Kunii; Shin-ichi Niwa; Yoshiaki Hagiwara; Masahiro Maeda; Tsutomu Seitoh; Toshimitsu Suzuki
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

5.  Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function.

Authors:  Raelene E Maser; M James Lenhard; Ryan T Pohlig; P Babu Balagopal
Journal:  J Diabetes Complications       Date:  2015-12-17       Impact factor: 2.852

6.  Novel roles for osteopontin and clusterin in peripheral motor and sensory axon regeneration.

Authors:  Megan C Wright; Ruifa Mi; Emmalynn Connor; Nicole Reed; Alka Vyas; Manula Alspalter; Giovanni Coppola; Daniel H Geschwind; Thomas M Brushart; Ahmet Höke
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

Review 7.  Proregenerative properties of ECM molecules.

Authors:  Stefan Plantman
Journal:  Biomed Res Int       Date:  2013-09-09       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.